PTE

PolarityTE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.180
-0.060
-4.84%
After Hours: 1.160 -0.02 -1.69% 16:47 03/27 EDT
OPEN
1.230
PREV CLOSE
1.240
HIGH
1.230
LOW
1.120
VOLUME
173.97K
TURNOVER
--
52 WEEK HIGH
12.10
52 WEEK LOW
0.7821
MARKET CAP
45.26M
P/E (TTM)
-0.3141
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PTE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PTE stock price target is 9.50 with a high estimate of 18.00 and a low estimate of 5.00.

EPS

PTE News

More
  • Earnings Release: Here's Why Analysts Cut Their PolarityTE, Inc. Price Target To US$10.17
  • Simply Wall St. · 03/15 14:26
  • The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
  • Benzinga · 03/13 11:52
  • PolarityTE, Inc.'s (PTE) Management on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/12 16:34
  • PolarityTE Reports Fiscal Year 2019 Financial Results
  • Business Wire · 03/12 12:00

Industry

Biotechnology & Medical Research
-2.43%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About PTE

PolarityTE, Inc., formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. The Company's PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. The Company focuses on various products, including SkinTE, OsteoTE, AngioTE, MyoTE, CartTE, AdiposeTE and NeuralTE. The Company, through SkinTE, is focused on supplying an autologous construct to regenerate a patient’s skin due to a variety of injuries and conditions.
More

Webull offers kinds of Polarityte Inc stock information, including NASDAQ:PTE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTE stock news, and many more online research tools to help you make informed decisions.